165 related articles for article (PubMed ID: 33369474)
1. Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
Saad H; Zahran MA; Hendy O; Abdel-Samiee M; Bedair HM; Abdelsameea E
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3725-3734. PubMed ID: 33369474
[TBL] [Abstract][Full Text] [Related]
2. Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
Wang B; Hsu CJ; Lee HL; Chou CH; Su CM; Yang SF; Tang CH
Int J Med Sci; 2018; 15(6):653-658. PubMed ID: 29725257
[TBL] [Abstract][Full Text] [Related]
3. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
[TBL] [Abstract][Full Text] [Related]
4. XRCC1 Gene Polymorphism Increases the Risk of Hepatocellular Carcinoma in Egyptian Population.
Naguib M; Helwa MM; Soliman MM; Abdel-Samiee M; Eljaky AM; Hammam O; Zaghla H; Abdelsameea E
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1031-1037. PubMed ID: 32334466
[TBL] [Abstract][Full Text] [Related]
5. Study of Toll-like Receptor 3 Gene Polymorphism as a Novel Risk Factor for HCV-related Hepatocellular Carcinoma in Egypt.
El-Sharawy S; Negm OE; Abd-Elsalam S; El-Sorogy HA; Shehata MAH
Curr Cancer Drug Targets; 2020; 20(5):382-389. PubMed ID: 32189594
[TBL] [Abstract][Full Text] [Related]
6. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
[TBL] [Abstract][Full Text] [Related]
7. Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.
Sriprapun M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Tangkijvanich P
Asian Pac J Cancer Prev; 2016; 17(4):2019-25. PubMed ID: 27221889
[TBL] [Abstract][Full Text] [Related]
8. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor rs3782905 and vitamin D binding protein rs7041 polymorphisms are associated with hepatocellular carcinoma susceptibility in cirrhotic HCV patients.
El-Masry AS; Medhat AM; El-Bendary M; Mohamed RH
BMC Med Genomics; 2023 Dec; 16(1):319. PubMed ID: 38066559
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of Cytokine Signaling-3 Gene Polymorphisms and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients in Egypt.
El Sharnoby A; Bedair HM; Raia GYS; Hamed N; Sabry A; Khalaf FA; Abd Elhamed MR; Abdel-Samiee M
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4253-4261. PubMed ID: 38156861
[TBL] [Abstract][Full Text] [Related]
12. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
[TBL] [Abstract][Full Text] [Related]
13. The Inter-Relation between Leptin Receptor (Q223R) Gene Polymorphism and the Risk of Egyptian Patients with HCC.
Karam HA; Bessa SS; Ali EMM; Diab T; Mohamed TM
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3557-3565. PubMed ID: 33369452
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinoma.
Zayed SA; Zahran NM; Khorshied MM; Abdel-Aziz AO; Mahmoud O; Morsy SA; Shousha HI; Elbaz TM; Nabeel MM; Harb ARK
J Med Virol; 2019 Aug; 91(8):1537-1544. PubMed ID: 30945308
[TBL] [Abstract][Full Text] [Related]
15. Association of genetic variants in the interleukin-18 gene promoter with risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus infection.
Bakr NM; Awad A; A Moustafa E
IUBMB Life; 2018 Feb; 70(2):165-174. PubMed ID: 29341496
[TBL] [Abstract][Full Text] [Related]
16. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
Elsayed HM; Nabiel Y; Sheta T
Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic polymorphism of BCL-2 (rs2279115) with susceptibility to HCV-related hepatocellular carcinoma.
Ahmed HS; Wahab EA; Elhady HA; Elgerby MM
Immunol Res; 2020 Aug; 68(4):189-197. PubMed ID: 32623689
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
[TBL] [Abstract][Full Text] [Related]
19. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
Chang KC; Tseng PL; Wu YY; Hung HC; Huang CM; Lu SN; Wang JH; Lee CM; Chen CH; Tsai MC; Yen YH; Lin MT; Wu CK; Huang CC; Chen HH; Hu TH
Clin Gastroenterol Hepatol; 2015 May; 13(5):1017-24. PubMed ID: 25460552
[TBL] [Abstract][Full Text] [Related]
20. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
Baghdadi I; Abu Ella K; El Shaaraway A; Elshayeb E; El-Rebey HS; El Hoseeny M; Naguib M; Nada A
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2047-2053. PubMed ID: 32711431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
